Welcome to our dedicated page for Pelagos Insurance Capital SEC filings (Ticker: FIHL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Pelagos Insurance Capital's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Pelagos Insurance Capital's regulatory disclosures and financial reporting.
Fidelis Insurance Holdings Ltd Chief Risk Officer Michael Justin Pearson filed an amended Form 3 to correct his reported holdings. The amendment increases his beneficial ownership by 17,000 common shares that were previously omitted, bringing the total to 171,461 common shares. This amount includes 40,996 restricted share units (RSUs) subject to time-based vesting, each representing a contingent right to receive one common share upon vesting.
Fidelis Insurance Holdings Ltd reports that certain Pine Brook entities and Howard H. Newman together may be deemed to beneficially own 7,209,921 Common Shares. As of March 31, 2026 this stake represents approximately 8.4% of the Common Shares outstanding. The calculation cites 86,318,571 Common Shares outstanding as of March 6, 2026. The filing is a joint statement under Rule 13d-1(k)(1) and attaches a Joint Filing Agreement dated April 24, 2026.
Adams Matthew J reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Matthew J. Adams received an equity grant of 6,517 common shares in the form of restricted share units. The grant was made at no cash cost per share and is subject to time-based vesting conditions. After this award, Adams directly holds 22,548 common shares, including the new RSUs, each representing a contingent right to receive one common share upon vesting.
Strickle Jonathan reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd Group Managing Director Jonathan Strickle received a grant of 71,725 common shares as equity compensation. The shares were awarded at no cash cost to him. Following this grant, he directly holds 140,186 common shares.
This total includes 123,806 restricted share units that are subject to time-based vesting conditions, each representing a contingent right to receive one common share when vesting requirements are met.
Pearson Michael Justin reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd reported that Chief Risk Officer Michael Justin Pearson received a grant of 33,107 common shares on March 30, 2026 at no cash cost per share. Following this award, he directly holds 187,568 common shares, including 74,103 restricted share units subject to time-based vesting conditions.
Kittinger Jason Allen reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd Chief Operating Officer Jason Allen Kittinger received a grant of 37,682 common shares on this Form 4 event, at a stated price of $0.0000 per share, indicating a share award rather than a market purchase. Following this grant, he directly holds 68,409 common shares. A footnote explains that this figure includes 60,908 restricted share units subject to time-based vesting conditions, each representing a contingent right to receive one common share upon vesting.
Iberg Cathleen Ann reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Cathleen Ann Iberg received an equity award of 6,517 common shares on a grant/award basis, with no cash paid per share. This award consists of 6,517 restricted share units subject to time-based vesting, each convertible into one common share upon vesting. Following this grant, she holds a total of 26,026 common shares and restricted share units directly, reflecting routine, compensation-related equity rather than an open‑market purchase or sale.
Dandridge Christine Elaine reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Christine Elaine Dandridge received an equity grant of 6,517 common shares as a stock award. The Form 4 shows these are restricted share units subject to time-based vesting, with each unit deliverable as one common share when it vests and no cash purchase price. Following this grant, Dandridge’s direct holdings reported in the filing total 19,618 common shares, reflecting a routine compensation-related award rather than an open-market share purchase or sale.
Fidelis Insurance Holdings Ltd director equity grant: Director Collis Charles Grant Ross received an award of 6,517 common shares in the form of restricted share units at a price of $0.00 per share as compensation. These RSUs are subject to time-based vesting, and each unit converts into one common share upon vesting. Following this award, Ross directly holds 11,948 common shares, reflecting a routine, non‑market equity compensation grant rather than an open‑market purchase.
Fidelis Insurance Holdings Ltd reported that its Chief Financial Officer, Allan Carl Decleir, acquired 19,520 common shares as a grant or award on March 30, 2026 at a stated price of $0.00 per share. After this compensation-related award, he directly holds 191,919 common shares. This direct position includes 89,790 restricted share units (RSUs) that are subject to time-based vesting conditions, with each RSU representing a contingent right to receive one common share upon vesting.